T0	MissingData 15939 16073	we collected key baseline and outcome data, but did not call patients back for study visits for detailed assessment of quality of life
T1	MissingData 16608 16679	we do not have complete information about adherence to study medication
T2	OutcomeMeasures 16452 16553	we did not include other baseline measurements such as amount of blood in CT scan or systemic illness
T3	PrecisionOfMeasurement 16555 16593	nor did we do close on-site monitoring
T4	StudyTeam 16830 16875	the possibility of unmasking of investigators
T5	ResponsivenessOfMeasurement 17068 17233	An effect of magnesium treatment on cognitive symptoms—which are common after aneurysmal subarachnoid haemorrhage—might have been missed by the modified Rankin Scale
T6	FollowUpDuration 17371 17404	a benefit might be detected later
T7	Intervention 18088 18200	time to treatment with magnesium in MASH 2 might not have been short enough to ameliorate acute ischaemic injury
T8	OutcomeMeasures 16359 16429	we did not include delayed cerebral haemorrhage as a secondary outcome
T9	MissingData 16681 16747	We did not require magnesium concentration to be routinely checked
